INS and Hypoglycemia: To explore whether endogenous AVP/V1bR signaling contributed to hypoglycemia-induced glucagon secretion, we injected WT mice with a selective V1bR antagonist (SSR149415; 25 mg/kg, i.p.)(33) 30 minutes prior to insulin administration.